Global Fabry Disease Treatment Market Size is valued at USD 1735.8 Mn in 2024 and is predicted to reach USD 3839.8 Mn by the year 2034 at an 8.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: As medical professionals, patients, and the general public become more aware of rare diseases such as Fabry disease, the demand for effective treatments is expected to increase. Continued research t...
Report ID: 1451 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Acute Vulvovaginal Candidiasis Market Size is valued at USD 339.50 Million in 2024 and is predicted to reach USD 507.32 Million by the year 2034 at a CAGR of 4.2% during the forecast period for 2025-2034. The acute vulvovaginal candidiasis market includes the development of several treatments and medications for the treatment of acute vulvovaginal candidiasis. The candida albicans fungus causes acute vulvovaginal candidiasis (VVC), which is al...
Report ID: 1232 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Global Lyophilization Services for Biopharmaceuticals Market Size is valued at USD 984.1 Mn in 2024 and is predicted to reach USD 2861.4 Mn by the year 2034 at an 11.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing prevalence of significant chronic diseases, coupled with improving healthcare infrastructure in emerging markets, fuels the demand for biopharmaceuticals. ...
Report ID: 1350 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 175
Global PD-1 and PD-L1 Inhibitors Market Size is valued at USD 48.7 Billion in 2024 and is predicted to reach USD 166.9 Billion by the year 2034 at a 13.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Rising cancer patients, sophisticated healthcare systems, and substantial healthcare expenditures propel the market. The industry has been further supported by developing combin...
Report ID: 1115 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global In Vitro Diagnostic (IVD) Reagents Market Size is valued at USD 59.3 Bn in 2024 and is predicted to reach USD 107.2 Bn by the year 2034 at a 6.2% CAGR during the forecast period for 2025-2034. In vitro diagnostic (IVD) reagents are crucial chemical compounds employed in laboratory analyses to examine samples obtained from the human body, such as blood, urine, and tissue. These substances are essential for the identification of diseases, t...
Report ID: 2452 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Eldercare-Assistive Robots Market Size is valued at USD 2.7 Bn in 2024 and is predicted to reach USD 8.5 Bn by the year 2034 at a 11.9% CAGR during the forecast period for 2025-2034. Eldercare assistive robots are specifically engineered machines created to aid senior individuals in performing daily activities and enhance their overall well-being. These robots can enhance the ability of elderly individuals to maintain their inde...
Report ID: 2469 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Pulsed Field Ablation Market Size is valued at USD 185.6 Mn in 2024 and is predicted to reach USD 3980.4 Mn by the year 2034 at a 36.0% CAGR during the forecast period for 2025-2034. Pulsed Field Ablation (PFA) is a minimally invasive cardiac procedure for treating irregular heart rhythms like atrial fibrillation. It involves delivering high-energy electrical pulses through catheters to create precise lesions or scar tissue on the heart, ...
Report ID: 2181 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Global Orphan Drugs CDMO Market Size is valued at USD 13.5 Bn in 2024 and is predicted to reach USD 27.6 Bn by the year 2034 at a 7.5% CAGR during the forecast period for 2025-2034. Orphan drugs, also known as orphan medicines or orphan therapies, are pharmaceuticals designed to treat rare medical illnesses known as orphan diseases. These disorders often impact a small proportion of the population, making them commercially undesirable for drug c...
Report ID: 2150 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Global Clinical Trials Manufacturing and Supply Outsourcing Market Size is valued at USD 13.4 Bn in 2024 and is predicted to reach USD 22.4 Bn by the year 2034 at a 7.3% CAGR during the forecast period for 2025-2034. Clinical trial manufacturing and supply outsourcing is a strategic technique utilized by pharmaceutical and biotechnology businesses to generate the investigational medications and supplies required for clinical trials efficiently a...
Report ID: 2158 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Global Medical Isotope Production Market Size is valued at USD 4.2 Bn in 2024 and is predicted to reach USD 8.4 Bn by the year 2034 at a 7.3% CAGR during the forecast period for 2025-2034. Medical isotopes, also known as radioisotopes, are radioactive atoms used in medical diagnostics and treatments. They play a critical role in imaging techniques like PET and SPECT scans and in therapies for diseases such as cancer. Producing these isotopes req...
Report ID: 3013 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Pharmaceuticals